Program Schedule

Interactive Panelist

Session: Interactive Session: Laboratory Diagnosis of Infectious Diseases: Case-Based
Saturday, October 11, 2014: 10:50 AM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
Angela Caliendo, MD, PhD, FIDSA, Medicine, Alpert Medical School of Brown University, Providence, RI

Angela M. Caliendo, MD, PhD is Professor and Executive Vice Chair of Medicine and Director of the Division of General Internal Medicine. She received a PhD (Biochemistry) and MD from Case Western Reserve University School of Medicine and completed an internship and residency in Internal Medicine at Brigham and Women’s Hospital in Boston, MA and an Infectious Diseases fellowship at Massachusetts General Hospital, Boston MA. Dr. Caliendo was a Co-Chairholder of the CLSI Subcommittee on Quantitative Molecular Diagnostics for Infectious Diseases and served as a member of the CLSI Subcommittee on Genotyping for Infectious Diseases, and an Advisor on the Subcommittee on Antiviral Susceptibility Testing. In 2004, she served as the President of the Association of Molecular Pathology and currently is a member of the Professional Relations Committee. She is currently Past President of the Pan-American Society for Clinical Virology and served as a Council Member from 2002 through 2006. She is a member of the American Society for Microbiology and a Fellow in the Infectious Diseases Society of American, and a member of the CAP Microbiology Resource Committee. She has been co-director of the ACTG Quantitative CMV working group and the Quantitative HCV working group, which have evaluated the performance characteristics of CMV and HCV viral load assays. Dr. Caliendo is an Editor of the Journal of Clinical Micorbiology, Associate Editor for the Journal of Clinical Virology, and past Editor of Clinical Microbiology Reviews, a past member of the Editorial Board for the Journal of Clinical Microbiology, a Virology Section Editor for the Manual of Clinical Microbiology (9th, 10th, 11th Ed), and the Infectious Diseases Section Editor for Molecular Pathology and Clinical Practice. Dr. Caliendo has extensive experience performing and developing molecular diagnostic tests for the detection and quantitation of infectious diseases. She has developed molecular assays for the detection of a variety of pathogens including Mycoplasma pneumoniae, Chlamydia pneumoniae, HSV, Trichomonas vaginalis, the mecA gene (methicillin resistance in Staphylococcus aureus), and EBV viral load. Dr. Caliendo has experience in the design and execution of multi-center clinical studies, she has Chaired working groups that have evaluated various CMV, HCV, and HBV viral load assays and her laboratory provides infrastructure and molecular testing for numerous multi-center clinical studies. She also is a member of the Aspergillus Technology Consortium, which was created to establish a repository of clinical specimens from subjects diagnosed with or at risk of Aspergillus infections and to test new diagnostic assays for Aspergillus infections.

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek